Related Party Transactions (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Related Party Transaction [Line Items]
Unpaid accrued interest expenses	$ 220,488		$ 220,488		$ 87,632
Cost of revenue	25,373	$ 55,817	52,127	$ 156,665
Revenues		28,555	20,729	77,719
Development expenses incurred	1,978,756	1,671,187	4,063,404	3,370,070
Research and development expense		19,618		39,344
COVID 19 Antigen Rapid Test Kits Sales [Member]
Related Party Transaction [Line Items]
Revenues		12,541		12,541
Manufacturing Service Agreement [Member]
Related Party Transaction [Line Items]
Incurred costs
Manufacturing Service Agreement [Member] | COVID 19 Antigen Rapid Test Kits Sales [Member]
Related Party Transaction [Line Items]
Accounts payable					323
Accounts receivable	21,872		21,872		27,208
Product Co Development Agreement [Member]
Related Party Transaction [Line Items]
Development expenses incurred	101,244	74,733	191,838	152,196
Advance payment			138,615		26,511
Product Co Development Agreement [Member] | Patents [Member]
Related Party Transaction [Line Items]
Non exclusive use of patents fee	285,263		569,862
Related Pary [Member]
Related Party Transaction [Line Items]
Interest expense incurred related party	101,777	22,637	132,855	26,057
Related Party [Member]
Related Party Transaction [Line Items]
Cost of revenue				46,635
Accounts receivable
Development expenses incurred	386,507	74,733	761,700	152,196
Related Party [Member] | Sales and Marketing Agreement [Member]
Related Party Transaction [Line Items]
Cost of revenue				$ 46,635